Words by Josh Hardman. *** We have barely kicked off 2025 and already a handful of ketamine-related news stories have emerged. In this ketamine-focused round-up, we explore: To continue reading, please log in or join Pα+… Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.

Source

Previous articlePα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring
Next articleNeeka Levy and Zach Skiles – Healing Ukraine Trauma